Chemotherapy as treatment of primary and recurrent small cell lung cancer
W Schuette - Lung Cancer, 2001 - Elsevier
Chemotherapy is the treatment of choice in metastatic stage of small-cell lung cancer
(SCLC). Radiation therapy, surgery and other forms of therapy are only included in special …
(SCLC). Radiation therapy, surgery and other forms of therapy are only included in special …
Management of small cell lung cancer
KK Ciombor, CMS Rocha Lima - Current Treatment Options in Oncology, 2006 - Springer
Opinion statement Small cell lung cancer (SCLC) is an aggressive type of lung cancer
characterized by rapid growth and early metastasis. It is chemosensitive and radiosensitive …
characterized by rapid growth and early metastasis. It is chemosensitive and radiosensitive …
Options for first-and second-line therapy in small cell lung cancer—a workshop discussion
N Thatcher, J Eckardt, M Green - Lung Cancer, 2003 - Elsevier
In a case study-based workshop, physicians were asked to discuss various aspects of
patient management in small cell lung cancer (SCLC). For first-line chemotherapy, most …
patient management in small cell lung cancer (SCLC). For first-line chemotherapy, most …
First-line chemotherapy in metastatic small-cell lung cancer (SCLC)
M Wolf, S Tebbe, T Fink - Lung Cancer, 2004 - Elsevier
The overall treatment results in metastatic small-cell lung cancer have not been changed in
the last decades. The prognosis of the disease is still poor with median survival times of less …
the last decades. The prognosis of the disease is still poor with median survival times of less …
Treatment of small cell lung cancer
A Kurup, NH Hanna - Critical reviews in oncology/hematology, 2004 - Elsevier
The incidence of small cell lung cancer (SCLC) is declining in the United States (US). SCLC
is nearly universally smoking-related and is very sensitive to both chemotherapy and …
is nearly universally smoking-related and is very sensitive to both chemotherapy and …
Chemotherapy for small cell lung cancer
AB Sandler - Seminars in oncology, 2003 - Elsevier
There were approximately 42,000 new cases of small cell lung cancer (SCLC) in 2002.
Despite its initial sensitivity to chemotherapy, only 10% of all SCLC patients will have …
Despite its initial sensitivity to chemotherapy, only 10% of all SCLC patients will have …
Second-line treatment of small-cell lung cancer. The case for systemic chemotherapy.
JR Eckardt - Oncology (Williston Park, NY), 2003 - europepmc.org
Small-cell lung cancer is an aggressive tumor associated with high rates of regional or
distant metastases at diagnosis. Although highly chemosensitive to agents given in the first …
distant metastases at diagnosis. Although highly chemosensitive to agents given in the first …
Update on new drugs in small cell lung cancer
L Horn, EL Castellanos, DH Johnson - Expert Opinion on …, 2011 - Taylor & Francis
Introduction: Small cell lung cancer (SCLC) will account for 25,000 to 32,000 new lung
cancer cases in the USA in 2010. Current treatment approaches include platinum-based …
cancer cases in the USA in 2010. Current treatment approaches include platinum-based …
[HTML][HTML] Chemotherapy for small cell lung cancer: a comprehensive review
SM Karim, J Zekri - Oncology reviews, 2012 - ncbi.nlm.nih.gov
Combination chemotherapy is the current strategy of choice for treatment of small cell lung
cancer (SCLC). Platinum containing combination regimens are superior to non-platinum …
cancer (SCLC). Platinum containing combination regimens are superior to non-platinum …
[HTML][HTML] Chemotherapy advances in small cell lung cancer
G Rosti, O Carminati, M Monti, S Tamberi… - Annals of …, 2006 - Elsevier
Small cell lung cancer accounts for 13–15% of all lung cancer worldwide. There has been a
decrease in the number of cases, with no clear explanation, except probably to changing in …
decrease in the number of cases, with no clear explanation, except probably to changing in …